| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | See Remarks | President and COO
1 company
Simon Barry J. serves as a Director at IBRX. Across recent SEC filings that breaks down to 0 buys and 30 sells. Those positions are worth an estimated $29.9M at current prices.
Historically, Simon Barry J.'s trades have earned a strong insider score of 79/100 across 3 rated trades. Over a 12-month horizon, 100.0% of those trades were profitable, with an average 12-month return of +76.6%.
The biggest single holding is IBRX (~$29.9M) as Director. The recent filings there lean toward selling, a net 1,424,100 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 5, 2026 | IBRX Immunitybio, Inc. | Director | Sell10b5-1 | 25,000 | $10.75 | $268,760.00 | -0.9% | - | - | |
| Jun 24, 2026 | IBRX Immunitybio, Inc. | Director | Sell10b5-1 | 25,000 | $7.88 | $196,907.50 | -0.9% | +19.1% | - | |
| Jun 4, 2026 | IBRX Immunitybio, Inc. | Director | Sell10b5-1 | 23,033 | $7.18 | $165,305.54 | -0.8% | +9.1% | - | |
| Feb 24, 2026 | IBRX Immunitybio, Inc. | Director | Sell10b5-1 | 75,000 | $12.01 | $900,787.50 | -2.6% | -31.4% | - | |
| Feb 23, 2026 | IBRX Immunitybio, Inc. | Director | Sale+OE10b5-1 | 175,000 | $10.19 | $1,783,601.50 | -5.6% | -19.3% | - | |
| Jan 20, 2026 | IBRX Immunitybio, Inc. | Director | Sell10b5-1 | 151,967 | $7.20 | $1,094,296.68 | -4.7% | +26.5% | - | |
| May 25, 2021 | IBRX Immunitybio, Inc. | Director | Sell | 125,000 | $16.14 | $2,018,056.87 | -3.9% | -31.0% | -77.8% | |
| Feb 5, 2021 | IBRX Immunitybio, Inc. | See Remarks | Sale+OE | 22,100 | $23.09 | $510,266.90 | -0.7% | - | - | |
| Feb 2, 2021 | IBRX Immunitybio, Inc. | See Remarks | Sale+OE | 82,070 | $20.65 | $1,694,802.95 | -2.5% | - | - | |
| Jan 28, 2021 | IBRX Immunitybio, Inc. | See Remarks | Sale+OE | 47,930 | $20.59 | $987,066.96 | -1.5% | - | - |